The Role of Na⁺-H⁺ Exchanger Isoform 1 in Aldosterone-Induced Glomerulosclerosis in Vivo

REFERENCES

• Stier CTJr, Rocha R, Chander PN. Effect of aldosterone and MR blockade on the brain and the kidney. Heart Fail Rev. 2005;10:53–62.
   PubMed Web of Science ®Google Scholar
• Marney AM, Brown NJ. Aldosterone and end-organ damage. Clin Sci. 2007;113(6):267–278.
   Google Scholar
• Young MJ. Mechanisms of mineralocorticoid receptor-mediated cardiac fibrosis and vascular inflammation. Curr Opin Nephrol Hypertens. 2008;17:174–180.
   PubMed Web of Science ®Google Scholar
• Lai L, Chen J, Hao CM, Lin S, Gu Y. Aldosterone promotes fibronectin production through a Smad2-dependent TGF-β1 pathway in mesangial cells. Biochem Biophys Res Comm. 2006;348:70–75.
   PubMed Web of Science ®Google Scholar
• Karmazyn M, Sawyer M, Fliegel L. The Na+/H+ exchanger: a target for cardiac thearapeutic intervention. Current Drug Targets—Cardiovascular and Haematological Disorders. 2005;5:323–335.
   PubMedGoogle Scholar
• Baartscheer A, Schumacher CA, van Borren MM, Belterman CN, Chronic inhibition of Na+/H+-exchanger attenuates cardiac hypertrophy and prevents cellular remodeling in heart failure. Cardiovasc Res. 2005;65:83–92.
   PubMedGoogle Scholar
• Huang W, Xu C, Kahng KW, Noble NA, Border WA, Huang Y. Aldosterone and TGF-β1 synergistically increase PAI-1 and decrease matrix degradation in rat renal mesangial and fibroblast cells. Am J Physiol Renal Physiol. 2008;294:F1287–F1295.
   Google Scholar
• Yuan J, Jia R, Bao Y. Beneficial effects of spironolactone on glomerular injury in streptozotocin-induced diabetic rats. J Renin Angiotensin Aldosterone Syst. 2007;8:118–126.
   PubMedGoogle Scholar
• Nishioka T, Suzuki M, Onishi K, Takakura N, Eplerenone attenuates myocardial fibrosis in the angiotensin II-induced hypertensive mouse: Involvement of tenascin-C induced by aldosterone-mediated inflammation. J Cardiovasc Pharmacol. 2007;49:261–268.
   Web of Science ®Google Scholar
• Chun TY, Chander PN, Kim JW, Pratt JH, Stier CTJr.. Aldosterone, but not angiotensin II, increases profibrotic factors in kidney of adrenalectomized stroke-prone spontaneously hypertensive rats. Am J Physiol Endocrinol Metab. 2008;295:E305–E312.
   Google Scholar
• Nagai Y, Yao L, Kobori H, Temporary angiotensin II blockade at the prediabetic stage attenuates the development of renal injury in type 2 diabetic rats. J Am Soc Nephrol. 2005;16:703–711.
   PubMedGoogle Scholar
• Fan Y-Y, Baba R, Nagai Y, Augmentation of intrarenal angiotensin II levels in uninephrectomized aldosterone/salt-treated hypertensive rats: Reno-protective effects of the ultrahigh dose of olmesartan. Hypertens Res. 2006;29:169–178.
   PubMedGoogle Scholar
• Kobori H, Ozawa Y, Suzaki Y, Nishiyama A. Enhanced intrarenal angiotensinogen contributes to early renal injury in spontaneously hypertensive rats. J Am Soc Nephrol. 2005;16:2073–2080.
   PubMed Web of Science ®Google Scholar
• Li C, Yang CW, Park CW, Long-term treatment with ramipril attenuates renal osteopontin expression in diabetic rats. Kidney Int. 2003;63:454–463.
   PubMedGoogle Scholar
• Teraishi K, Kurata H, Nakajima A, Takaoka M, Matsumura Y. Preventive effect of Y-27632, a selective Rho-kinase inhibitor, on ischemia/reperfusion-induced acute renal failure in rats. Eur J Pharmacol. 2004;505:205–211.
   PubMed Web of Science ®Google Scholar
• Anderson S, Meyer TW, Rennke HG, Brenner BM. Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass. J Clin Invest. 1985;76:612–619.
   PubMed Web of Science ®Google Scholar
• Lax DS, Benstein JA, Tolbert E, Effects of salt restriction on renal growth and glumerular injury in rats with remnant kidneys. Kidney Int. 1992;41:1527–1534.
   PubMed Web of Science ®Google Scholar
• Hené RJ, Boer P, Koomans HA, Mees EJ. Plasma aldosterone concentrations in chronic renal disease. Kidney Int. 1982;21:98–101.
   PubMed Web of Science ®Google Scholar
• Fredersdorf S, Endemann DH, Luchner A, Increased aldosterone levels in a model of Type 2 diabetes mellitus. Exp Clin Endocrinol Diabetes. 2009;117:15–20.
   PubMed Web of Science ®Google Scholar
• Sato A, Hayashi K, Naruse M, Saruta T. Effectiveness of aldosterone blockade in patients with diabetic nephropathy. Hypertension. 2003;41:64–68.
   PubMed Web of Science ®Google Scholar
• Hou FF, Zhang X, Zhang GH, Efficacy and safety of benazepril for advanced chronic renal insufficiency. N Engl J Med. 2006;354:131–140.
   PubMed Web of Science ®Google Scholar
• Terada Y, Kuwana H, Kobayashi T, Aldosterone-stimulated SGK1 activity mediates profibrotic signaling in the mesangium. Journal of the American Society of Nephrology. 2008;19:298–309.
   PubMed Web of Science ®Google Scholar
• Harguindey S, Orive G, Luis Pedraz J, Paradiso A, Reshkin SJ. The role of pH dynomics and the Na+/H+ antiporter in the etiopathogenesis and treatment of cancer. Two faces of the same coin—one single nature. Biochimica et Biophysica Acta. 2005;1756:1–24.
   PubMed Web of Science ®Google Scholar
• Baartscheer A, Hardziyenka M, Schumacher CA, Chronic inhibition of the Na+/H+ - exchanger causes regression of hypertrophy, heart failure, and ionic and electrophysiological remodelling. Br J Pharmacol. 2008;154:1266–1275.
   PubMed Web of Science ®Google Scholar
• Navarro-Lopez F, Coca A, Pare JC, Left ventricular hypertrophy in asymptomatic essential hypertension: Its relationship with aldosterone and the increase in sodium-proton exchanger activity. European Heart Journal. 1993;14:38–41.
   PubMedGoogle Scholar
• Karmazyn M, Liu Q, Gan XT, Brix BJ, Fliegel L. Aldosterone increases NHE-1 expression and induces NHE-1-dependent hypertrophy in neonatal rat ventricular myocytes. Hypertension. 2003;42:1171–1176.
   PubMedGoogle Scholar
• Ebata S, Muto S, Okada K, Aldosterone activates Na+/H+ exchange in vascular smooth muscle cells by nongenomic and genomic mechanisms. Kidney Int. 1999;56:1400–1412.
   PubMedGoogle Scholar
• Pinto V, Pinho MJ, Hopfer U, Jose PA, Soares-da-Silva P. Oxidative stress and the genomic regulation of aldosterone-stimulated NHE1 activity in SHR renal proximal tubular cells. Mol Cell Biochem. 2008;310:191–201.
   PubMed Web of Science ®Google Scholar
• Nangaku M. Mechanisms of tubulointerstitial injury in the kidney: Final common pathways to end-stage renal failure. Intern Med. 2004;43:9–17.
   PubMed Web of Science ®Google Scholar
• Takeda M, Tatsumi T, Matsunaga S, Spironolactone modulates expressions of cardiac mineralocorticoid receptor and 11β-hydroxysteroid dehydrogenase 2 and prevents ventricular remodeling in post-infarct rat hearts. Hypertens Res. 2007;30:427–437.
   PubMedGoogle Scholar
• Funder JW, Mihailaidou AS. Aldosterone and mineralocorticoid receptors: Clinical studies and basic biology. Mol Cell Endocrinol. 2009;301:2–6.
   PubMed Web of Science ®Google Scholar
• Kagami S, Border WA, Miller DE, Noble NA. Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-β expression in rat glomerular mesangial cells. J Clin Invest. 1994;93:2431–2437.
   PubMed Web of Science ®Google Scholar
• Anderson PW, Zhang XY, Tian J, Insulin and angiotensin II are additive in stimulating TGF-β1 and matrix mRNAs in mesangial cells. Kidney Int. 1996;50:745–753.
   PubMed Web of Science ®Google Scholar
• Uchiyama-Tanaka Y, Matsubara H, Mori Y, Involvement of HB-EGF and EGF receptor transactivation in TGF-β-mediated fibronectin expression in mesangial cells. Kidney Int. 2002;62:799–808.
   PubMed Web of Science ®Google Scholar
• Guo B, Koya D, Isono M, Sugimoto T, Kashiwagi A, Haneda M. Peroxisome proliferator-activated receptor-c ligands inhibit TGF-β1-induced fibronectin expression in glomerular mesangial cells. Diabetes. 2004;53:200–208.
   PubMed Web of Science ®Google Scholar
• Reiss K, Meggs LG, Li P, Olivetti G, Capasso J, Anversa P. Upregulation of IGF1, IGF1-receptor, and late growthrelated genes in ventricular myocytes acutely after infarction in rats. J Cell Physiol. 1994;158:160–168.
   PubMedGoogle Scholar
• Johnson RJ, Alpers CE, Yoshimura A, Renal injury from angiotensin II-mediated hypertension. Hypertension. 1992;19:464–474.
   PubMed Web of Science ®Google Scholar
• Peng H, Carretero OA, Raij L, Yang F, Kapke A, Rhaleb NE. Antifibrotic effects of N-acetyl-seryl-aspartyl-Lysyl-proline on the heart and kidney in aldosterone-salt hypertensive rats. Hypertension. 2001;37:794–800.
   PubMed Web of Science ®Google Scholar